Lung Cancer,SCLC (Small Cell Lung Cancer) FDA Grants FTD to SN Bioscience SNB-101 for Treating SCLC May 14, 2024
Esophageal Cancer,Gastrointestinal Cancer FDA Designates ODD to 9MW2821 for Treating Esophageal Cancer May 12, 2024
Breast Cancer,HER2-,HER2+ FDA Clears Biotheryx’s IND of Btx-9341 for HR+/HER2- Breast Cancer May 11, 2024
Colorectal Cancer,Gastrointestinal Cancer FDA Greenlights Colosense™- Geneoscopy's mt-sRNA CRC Screening Test May 10, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) FDA Accepts Priority Review to Merus’ BLA for Zeno in NRG1+ NSCLC and PDAC May 09, 2024